As a part of the Keck School of Medicine of USC, the CardioVascular Thoracic Institute offers a full range of programs and services to address cardiovascular concerns. We offer state-of-the-art screenings, diagnostic tests, innovative non-invasive treatments and specialized therapies including transplant surgery. Whatever the level of care you require, our team will design and implement the health plan that works best for you.
At the USC CardioVascular Thoracic Institute, we are pushing the boundaries of our field. We are exploring new methods to better treat our patients, including the development and refinement of new technologies. Innovative robotic therapy and heart valve replacements are just two examples of treatments that our surgeons have helped to perfect.
To treat cardiovascular and thoracic disease, medicine is shifting toward organ-based therapies and an interdisciplinary model, so that expertise from a variety of fields can be shared. This progressive model forms the basis of our patient care delivery. Our cardiologists no longer hand off cases to our cardiac surgeons. Instead, medical and surgical experts collaborate in planning the treatment and follow-up care for their patients, making the best decisions possible and using the best therapies available.
According to the American Heart Association, one in three American adults has some form of cardiovascular disease--high blood pressure, coronary heart disease, heart failure, stroke or congenital cardiovascular defects.
Heart disease is the leading cause of death in the United States for both men and women and for all racial and ethnic groups. Each year, 1.5 million Americans suffer heart attacks--and one-third of those are fatal. Each day, nearly 2,500 Americans die of cardiovascular disease.
At the USC CardioVascular Thoracic Institute, we are dedicated to improving these statistics. Our physicians offer advanced, patient-centered care to individuals whose health is threatened by cardiovascular disease, while our scientists are pursuing research that will lead to more effective treatment and prevention therapies.
Our surgeons, along with their extensive clinical, research, and administrative staff, offer comprehensive state of the art therapy for all surgical diseases of the chest including:
In addition, USC surgeons offer a complete spectrum of care for pediatric cardiac and thoracic disease including Congenital Heart Disease, Pediatric Thoracic Diseases, End Stage Cardiac Disease, Heart Transplantation, End-Stage Pulmonary Disease and Lung Transplantation.
USC cardiothoracic surgeons have engaged in a new era of cardiothoracic surgery that promises to significantly improve treatment of the most common forms of heart and lung diseases by introducing minimally invasive technology to cardiothoracic surgery. With the development of the minimally invasive cardiothoracic surgical technology, which includes robotic surgery, USC surgeons can achieve results that are safe, precise and reproducible; but with significant benefits to the patient in terms of decreased postoperative pain, recovery time, cost and cosmetic result.
CardioVascular Thoracic Institute
1520 San Pablo Street
HCCII, Suite 4300
Los Angeles, CA 90033
This website was developed in 2011 as a service provided by the USC CardioVascular Thoracic Institute. This website provides selected information available about cardiovascular and thoracic surgery which may become out of date over time. It is important that consumers see a healthcare professional for detailed information about medical conditions and treatment. This information is not intended to be a substitute for the advice of a healthcare professional, or a recommendation for any particular treatment plan. The USC CardioVascular Thoracic Institute has made and will continue to make efforts to include accurate and up-to-date information on this website.